Capricor Therapeutics | CAPR - Sales Revenues


Capricor Therapeutics reported $11.13M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Bioline Rx USD 477K 283K Mar/2026
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Cipla INR 71.19B 5.78B Jun/2026
Cytokinetics USD 28.6M 9.25M Jun/2026
Geron USD 57.48M 5.64M Jun/2026
Grifols EUR 2B 306.7M Mar/2026
J&J USD 25.31B 1.21B Jun/2026
Plus Therapeutics USD 1.03M 339K Mar/2026
Prothena USD 51.08M 51.06M Mar/2026
PTC Therapeutics USD 361M 88M Jun/2026
Sarepta Therapeutics USD 401.3M 329.5M Jun/2026